The Daily Ledger

Keeping a record of today

ELISA

Santa Cruz Biotech New Antibodies for Cancer Research

Santa Cruz Biotechnology’s Commitment to Cancer Research Santa Cruz Biotechnology (SCBT) has long been a significant player in the life science research market, offering a vast catalog of antibodies, proteins, and other research reagents. Their commitment to cancer research is…

Santa Cruz Biotech’s Breakthrough Cancer Treatment

A Novel Approach to Cancer Treatment Santa Cruz Biotech’s groundbreaking research has yielded a promising new cancer treatment, focusing on a previously unexplored mechanism within cancer cells. Instead of targeting the cancerous cells directly, the treatment, codenamed “Project Chimera,” focuses…